Expanded FDA Clearance for SmartMammo™ Solution
SmartMammo™’s AI algorithm is now approved by the FDA to work with GE HealthCare’s Senographe Pristina™ mammography systems. This advancement enhances access to advanced cancer detection.
Collaboration Between DeepHealth and GE HealthCare
The recent clearance showcases RadNet’s DeepHealth and GE HealthCare's collaboration. By combining SmartMammo’s advanced technology with GE HealthCare’s mammography systems, the partnership aims to transform the methods used in breast cancer diagnosis.
The Impact of SmartMammo on Breast Cancer Screening
Recently announced from Somerville, Massachusetts, DeepHealth, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received expanded FDA 510(k) clearance. This software is designed to improve mammography assessments and patient outcomes. SmartMammo Dx, the key AI component, was cleared in 2021 and now integrates seamlessly with other imaging systems to support enhanced clarity in medical screening processes.
Voices Behind the Technology
Kees Wesdorp, President and CEO of RadNet’s Digital Health segment, emphasized, “This FDA clearance allows us to expand access to high-quality breast cancer screening to more patients.” Incorporating SmartMammo with GE Health’s systems enables providers to utilize cutting-edge AI, addressing imaging challenges and enhancing patient care rapidly.
Advancements in Diagnostic Technology
SmartMammo Dx is integral to DeepHealth's comprehensive offerings, which include tools for interpreting digital breast tomosynthesis (DBT) mammograms with improved accuracy. The software is capable of detecting suspicious lesions and calcifications, assigning levels of suspicion that aid radiologists in diagnosing with precision.
Broadening the Reach of AI-Assisted Breast Cancer Detection
DeepHealth’s technologies have already facilitated millions of exams, significantly supporting breast cancer screening programs. This latest FDA clearance with GE HealthCare is expected to accelerate the adoption of these AI solutions, ensuring more patients receive effective screening services.
Commitment to Patient-Centric Care
The milestone achieved in the FDA clearance aligns with both DeepHealth and GE HealthCare’s dedication to developing interoperable and scalable imaging technologies. Their mutual goal is to establish a new standard in AI-powered breast imaging.
About RadNet and DeepHealth
RadNet, Inc. stands as a significant national provider of outpatient diagnostic imaging services, owning and operating around 399 facilities across various states. Beyond imaging services, RadNet offers innovative health technology solutions, evident in its extensive workforce comprising over 10,000 employees dedicated to enhancing diagnostic accuracy.
DeepHealth’s Role in Advancing Healthcare
DeepHealth, as part of RadNet, continues to redefine the healthcare landscape. With its range of AI-driven solutions, DeepHealth aims to foster technological advancements that enhance patient care across multiple health sectors, including breast, lung, prostate, and brain health.
Innovative AI Solutions for Radiologists
DeepHealth’s technology, powered by a cloud-native operating system, provides radiologists with essential tools to improve operational efficiency and patient diagnostic experiences globally. This innovative approach is helping to revolutionize cancer detection strategies, aiming for quicker and more accurate diagnoses.
Frequently Asked Questions
What is SmartMammo?
SmartMammo is an AI-driven mammography software developed by DeepHealth to improve breast cancer screening accuracy.
How does SmartMammo work?
It analyzes digital breast tomosynthesis (DBT) images to help radiologists identify potential risks more effectively.
What recent achievement did DeepHealth announce?
DeepHealth announced expanded FDA clearance for its SmartMammo solution, allowing compatibility with GE HealthCare’s systems.
What is the significance of this FDA clearance?
This clearance enhances patient access to reliable cancer screening, contributing to improved healthcare outcomes.
What is the mission of DeepHealth?
DeepHealth aims to empower breakthroughs in imaging and diagnostics through advanced artificial intelligence and informatics.
